v3.26.1
Share-based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation
The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 (in thousands):
 Three Months Ended
March 31,
  20262025
Cost of revenues$181 $52 
Research and development205 268 
Sales and marketing527 146 
General and administrative1,391 1,135 
      Total$2,304 $1,601 
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity for the three months ended March 31, 2026:
Outstanding — December 31, 20251,517,039 
Granted— 
Exercised(481)
Canceled(5,000)
Outstanding — March 31, 20261,511,558 
Exercisable — March 31, 2026409,138 
Schedule of Stock Options, Valuation Assumptions The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)10
Risk-free interest rate4.57 %
Volatility84.00 %
Expected dividend yield— %
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)3
Risk-free interest rate4.25 %
Volatility105.63 %
Expected dividend yield— %
Correlation coefficient0.3741
Schedule of Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity for the three months ended March 31, 2026:
Non-vested — December 31, 20251,846,156 
Granted2,451 
Vested(115,215)
Forfeited(47,551)
Non-vested — March 31, 20261,685,841